Cargando…
Costs, effectiveness, and safety associated with Chimeric Antigen Receptor (CAR) T-cell therapy: Results from a comprehensive cancer center
Real world effectiveness, toxicity and costs analyses from chimeric antigen receptor (CAR)-T cell therapy are of utmost relevance to determine whether and how to offer patients highly personalized immunotherapy. In this study, we aimed at describing CAR T-cells effectiveness, safety and costs in a P...
Autores principales: | Chacim, Sérgio, Monjardino, Teresa, Cunha, José Luís, Medeiros, Pedro, Redondo, Patrícia, Bento, Maria José, Mariz, José Mário |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733886/ https://www.ncbi.nlm.nih.gov/pubmed/36490296 http://dx.doi.org/10.1371/journal.pone.0278950 |
Ejemplares similares
-
Secondary Hemophagocytic Syndrome: The Importance of Clinical Suspicion
por: Oliveira, Cristina, et al.
Publicado: (2014) -
Chimeric Antigen Receptor beyond CAR-T Cells
por: Qin, Vicky Mengfei, et al.
Publicado: (2021) -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
por: Galli, Eugenio, et al.
Publicado: (2021) -
Humanized Chimeric Antigen Receptor (CAR) T cells
por: Kozani, Pouya Safarzadeh, et al.
Publicado: (2021) -
Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma
por: García-Guerrero, Estefanía, et al.
Publicado: (2020)